Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Hans‐Martin Otten"'
Autor:
Sietske C.M.W. van Nassau, Helene R. Voogdt-Pruis, Vincent M.W. de Jong, Hans-Martin Otten, Liselot B. Valkenburg-van Iersel, Bas J. Swarte, Tineke E. Buffart, Hans J. Pruijt, Leonie J. Mekenkamp, Miriam Koopman, Anne M. May
Publikováno v:
PEC Innovation, Vol 4, Iss , Pp 100300- (2024)
Objective: To improve sustainability of a patient decision aid for systemic treatment of metastatic colorectal cancer, we evaluated real-world experiences and identified ways to optimize decision aid content and future implementation. Methods: Semi-s
Externí odkaz:
https://doaj.org/article/7ff0631d8f624b958ba577f5a3ab8d28
Autor:
Aurelia H. M. deVries Schultink, Marie‐Rose B. S. Crombag, Erik vanWerkhoven, Hans‐Martin Otten, Andre M. Bergman, Jan H. M. Schellens, Alwin D. R. Huitema, Jos H. Beijnen
Publikováno v:
Cancer Medicine, Vol 8, Iss 4, Pp 1406-1415 (2019)
Abstract The incidence of neutropenia in metastatic castration‐resistant prostate cancer (mCRPC) patients treated with docetaxel has been reported to be lower compared to patients with other solid tumors treated with a similar dose. It is suggested
Externí odkaz:
https://doaj.org/article/915cd825bb7749d88d3c80c0290c56dc
Autor:
Noémie Kraaijpoel, Frits I. Mulder, Marc Carrier, Annabel van Lieshout, Tom Würdinger, Myron G. Best, Bart J.M. van Vlijmen, Yassene Mohammed, Luis Jara-Palomares, Pieter W. Kamphuisen, Marcello Di Nisio, Walter Ageno, Jan Beyer-Westendorf, Thomas Vanassche, Frederikus A. Klokm, Hans-Martin Otten, Mike J.L. Peters, Benilde Cosmi, Marije ten Wolde, Patrick M.M. Bossuyt, Harry R. Büller, Nick van Es
Publikováno v:
Thrombosis Update, Vol 2, Iss , Pp 100030- (2021)
Occult cancer is detected in about 5% of patients with unprovoked venous thromboembolism (VTE) in the 12 months following VTE diagnosis. Current guidance suggests conducting a ‘limited’ cancer screening in these patients, consisting of medical hi
Externí odkaz:
https://doaj.org/article/2dd9496a84fc4b7081e92959d00b7e2f
Autor:
Nick van Es, Marcello Di Nisio, Gabriela Cesarman, Ankie Kleinjan, Hans-Martin Otten, Isabelle Mahé, Ineke T. Wilts, Desirée C. Twint, Ettore Porreca, Oscar Arrieta, Alain Stépanian, Kirsten Smit, Michele De Tursi, Suzanne M. Bleker, Patrick M. Bossuyt, Rienk Nieuwland, Pieter W. Kamphuisen, Harry R. Büller
Publikováno v:
Haematologica, Vol 102, Iss 9 (2017)
In ambulatory patients with solid cancer, routine thromboprophylaxis to prevent venous thromboembolism is not recommended. Several risk prediction scores to identify cancer patients at high risk of venous thromboembolism have been proposed, but their
Externí odkaz:
https://doaj.org/article/77d002a752324e66b38d01ca68793735
Autor:
Marein Schimmel, Erfan Nur, Bart J. Biemond, Gerard J. van Mierlo, Shabnam Solati, Dees P. Brandjes, Hans-Martin Otten, John-John Schnog, Sacha Zeerleder
Publikováno v:
Haematologica, Vol 98, Iss 11 (2013)
Activated polymorphonuclear neutrophils play an important role in the pathogenesis of vaso-occlusive painful sickle cell crisis. Upon activation, polymorphonuclear neutrophils can form neutrophil extracellular traps. Neutrophil extracellular traps co
Externí odkaz:
https://doaj.org/article/363b9c1bed9c47ccaf465726ad09f9f6
Publikováno v:
Cancer Chemotherapy and Pharmacology. 90:417-419
Autor:
Walter Ageno, Marc Carrier, Patrick M.M. Bossuyt, Myron G. Best, Marcello Di Nisio, Frederikus A. Klokm, Mike J L Peters, Marije ten Wolde, Yassene Mohammed, Pieter Willem Kamphuisen, Thomas Wurdinger, Noémie Kraaijpoel, Benilde Cosmi, Frits I. Mulder, Annabel van Lieshout, Nick van Es, Jan Beyer-Westendorf, Hans-Martin Otten, Bart J.M. van Vlijmen, Luis Jara-Palomares, Harry R. Büller, Thomas Vanassche
Publikováno v:
Thrombosis Update, 2:100030. Elsevier BV
Thrombosis Update, Vol 2, Iss, Pp 100030-(2021)
Kraaijpoel, N, Mulder, F I, Carrier, M, van Lieshout, A, Würdinger, T, Best, M G, van Vlijmen, B J M, Mohammed, Y, Jara-Palomares, L, Kamphuisen, P W, di Nisio, M, Ageno, W, Beyer-Westendorf, J, Vanassche, T, Klokm, F A, Otten, H-M, Peters, M J L, Cosmi, B, Wolde, M T, Bossuyt, P M M, Büller, H R & van Es, N 2021, ' Novel biomarkers to detect occult cancer in patients with unprovoked venous thromboembolism : Rationale and design of the PLATO-VTE study ', Thrombosis Update, vol. 2, 100030 . https://doi.org/10.1016/j.tru.2020.100030
Thrombosis Update, Vol 2, Iss, Pp 100030-(2021)
Kraaijpoel, N, Mulder, F I, Carrier, M, van Lieshout, A, Würdinger, T, Best, M G, van Vlijmen, B J M, Mohammed, Y, Jara-Palomares, L, Kamphuisen, P W, di Nisio, M, Ageno, W, Beyer-Westendorf, J, Vanassche, T, Klokm, F A, Otten, H-M, Peters, M J L, Cosmi, B, Wolde, M T, Bossuyt, P M M, Büller, H R & van Es, N 2021, ' Novel biomarkers to detect occult cancer in patients with unprovoked venous thromboembolism : Rationale and design of the PLATO-VTE study ', Thrombosis Update, vol. 2, 100030 . https://doi.org/10.1016/j.tru.2020.100030
Occult cancer is detected in about 5% of patients with unprovoked venous thromboembolism (VTE) in the 12 months following VTE diagnosis. Current guidance suggests conducting a ‘limited’ cancer screening in these patients, consisting of medical hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::232df4c971368cc3a7124920055a7d38
https://hdl.handle.net/11383/2151173
https://hdl.handle.net/11383/2151173
Publikováno v:
European Journal of Cancer Care. 30
Objective Screening for hepatitis B virus (HBV) before chemotherapy is recommended by international guidelines; still, the HBV screening rate is low, and patients remain at risk for HBV reactivation (HBVr). Because HBVr is a serious and preventable c
Autor:
Grégoire Le Gal, Harry R. Büller, Frederiek F. van Doormaal, Pierre-Yves Salaun, Philippe Robin, Nick van Es, Hans-Martin Otten, Frits I. Mulder, Marc Carrier
Publikováno v:
Journal of thrombosis and haemostasis, 18(10), 2622-2628. Wiley-Blackwell
Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis
Background The Registro Informatizado de Pacientes con Enfermedad TromboEmbólica (RIETE) score and the Screening for Occult Malignancy in Patients with Idiopathic Venous Thromboembolism (SOME) risk scores aim to identify patients with acute unprovok
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b92111a4f3a61fc4a30a4515bee6e06
https://pure.amc.nl/en/publications/risk-scores-for-occult-cancer-in-patients-with-unprovoked-venous-thromboembolism-results-from-an-individual-patient-data-metaanalysis(60cb4066-861e-4aa0-b4d8-360dd72672e4).html
https://pure.amc.nl/en/publications/risk-scores-for-occult-cancer-in-patients-with-unprovoked-venous-thromboembolism-results-from-an-individual-patient-data-metaanalysis(60cb4066-861e-4aa0-b4d8-360dd72672e4).html
Autor:
Marije ten Wolde, Hans-Martin Otten, Marlène H. W. van de Poel, Karina Meijer, Edith M. Klappe, Lidwine W. Tick, Ingrid M. Bistervels, Erik H. Serné, Hugo ten Cate, Arina J. ten Cate-Hoek, Saskia Middeldorp, Guy Mostard, Manuela A. Joore, Elham E. Amin
Publikováno v:
Blood, 132(21), 2298-2304. AMER SOC HEMATOLOGY
Blood, 132, 21, pp. 2298-2304
Blood, 132(21), 2298-2304. American Society of Hematology
Amin, E E, Bistervels, I M, Meijer, K, Tick, L W, Middeldorp, S, Mostard, G, van de Poel, M, Serné, E H, Otten, H M, Klappe, E M, Joore, M A, ten Cate, H, ten Wolde, M & ten Cate-Hoek, A J 2018, ' Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis ', Blood, vol. 132, no. 21, pp. 2298-2304 . https://doi.org/10.1182/blood-2018-03-836783
Blood, 132, 2298-2304
Blood, 132(21), 2298-2304. The American Society of Hematology
Blood, 132, 21, pp. 2298-2304
Blood, 132(21), 2298-2304. American Society of Hematology
Amin, E E, Bistervels, I M, Meijer, K, Tick, L W, Middeldorp, S, Mostard, G, van de Poel, M, Serné, E H, Otten, H M, Klappe, E M, Joore, M A, ten Cate, H, ten Wolde, M & ten Cate-Hoek, A J 2018, ' Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis ', Blood, vol. 132, no. 21, pp. 2298-2304 . https://doi.org/10.1182/blood-2018-03-836783
Blood, 132, 2298-2304
Blood, 132(21), 2298-2304. The American Society of Hematology
Thus far, the association between residual vein occlusion and immediate compression therapy and postthrombotic syndrome is undetermined. Therefore, we investigated whether compression therapy immediately after diagnosis of deep vein thrombosis affect